Metric Finance
LearnFAQ
LearnFAQ

Learn / BNTC

NASDAQ: BNTC

Benitec Biopharma (BNTC) stock, explained like you're 5

Benitec Biopharma trades on the Nasdaq under the ticker BNTC. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 309 million dollars.

Ticker
BNTC
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Small cap, about 309 million dollars

Is Benitec Biopharma a small, medium or large cap company?

No. Benitec Biopharma is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 309 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Benitec Biopharma makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves BNTC stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • BNTC: Benitec Biopharma Inc Latest Stock Price, Analysis, News and Trading Ideas (Stocktwits)
  • Benitec Biopharma (Nasdaq:BNTC) Stock Analysis (Simply Wall Street)
  • Citizens reiterates Benitec Biopharma stock rating on FDA feedback (Investing.com)
  • Benitec Biopharma Inc. Stock 12‑Month Price Target Raised to $24.33, Implies 171% Upside (TradingView)
  • After Plunging 23.9% in 4 Weeks, Here's Why the Trend Might Reverse for Benitec Biopharma (BNTC) (Yahoo Finance)

Follow BNTC in your daily brief

Each trading day at 5 PM ET we post what happened to Benitec Biopharma and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow BNTC

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Benitec Biopharma stock

What does Benitec Biopharma do?

Benitec Biopharma trades on the Nasdaq under the ticker BNTC. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 309 million dollars.

What is the ticker symbol for Benitec Biopharma?

Benitec Biopharma trades under the ticker BNTC on the Nasdaq.

What is Benitec Biopharma's market cap?

Benitec Biopharma is a small cap stock with a market cap of about 309 million dollars.

How does Benitec Biopharma make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves BNTC stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow BNTC stock every day?

Add BNTC to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow BNTC daily

A free brief on Benitec Biopharma and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare BNTC: BNTC vs NVS, BNTC vs AZN, BNTC vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed